While these observations emphasize the important role that the activation of PI3K/AKT plays in the cancer radioresistance, we demonstrate that blocking the PI3K/AKT/mTOR pathway with RAD001 appears as a valuable mean to enhance the efficacy of radiation treatment in bladder cancer cells. Here, AKT1 is linked to urinary bladder cancer.